Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.87%
#3 Cysic Cysic +15.83%
#4 Fabric Protocol Fabric Protocol +12.01%
#5 Bedrock Bedrock +9.08%
#6 Cap Cap +8.32%
#7 stake.link stake.link +6.45%
#8 Pons Pons +5.85%
#9 Enso Enso +5.58%
#10 DUSK Network DUSK Network +4.98%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
주식 순위 #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
주가
$0.01345907
마지막 동기화: 2024-07-12
시가총액
$1.43M
변동 (1일)
22.16%
변동 (1년)
0.00%
국가
SE
거래 Idogen AB (publ) (IDOGEN)

카테고리

Healthcare
Idogen AB (publ) (IDOGEN)의 주가 이력
최고 종가: $0.01 (2024-07-01 기준)

최저 종가: $6.87 (2015-06-01 기준)
Idogen AB (publ)의 주가 이력 (2015 ~ 2026)
연간 주가 성과
연도 성과
2024 17.75%
2023 -33.56%
2022 -90.58%
2021 -53.76%
2020 -45.68%
2019 -53.15%
2018 -66.56%
2017 -52.66%
2016 54.52%
2015 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE